Pathogen: SARS-CoV-2

COCO-Long’Run

France
|
2024-2027
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Cardiac coherence

CON-VIDA

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

COPP2-study

The Netherlands
|
2020
  • General population
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Emergency department
  • SARS-CoV-2
  • Post-COVID-19